Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions

Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions

The use of antiplatelet agents is essential in percutaneous coronary interventions, both periprocedurally and in the post-interventional period. Procedural antiplatelet therapy, aiming to limit ischemic complications, is mostly administered with oral agents, including aspirin and P2Y12 inhibitors. H...

Full description

Saved in:
Bibliographic Details
Main Authors: Nikolaos Pyrpyris, Kyriakos Dimitriadis, Konstantinos G. Kyriakoulis, Stergios Soulaidopoulos, Panagiotis Tsioufis, Aggelos Papanikolaou, Nikolaos G. Baikoussis, Alexios Antonopoulos, Konstantinos Aznaouridis, Konstantinos Tsioufis
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pharmaceuticals
Subjects:
cangrelor
antiplatelet
percutaneous coronary intervention
cardiogenic shock
microcirculation
coronary artery disease
Online Access:https://www.mdpi.com/1424-8247/18/3/432
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/3/432

Similar Items